Joshua Schulman

Joshua Schulman has extensive work experience in various roles and industries. Joshua is currently serving as the Chief Science Officer at Joy Ventures. Prior to this, they worked as a Principal at Cortical Consulting for almost nine years. Joshua was also the SVP of Partnerships and Innovation at Genetika+ for a year. Additionally, they served as an Investment Associate for Digital Health at Medison Pharma. Joshua held multiple positions at MaxQ AI, including Senior Vice President of Clinical Innovation and VP of Clinical, Regulatory, and Quality Affairs. Joshua was also the VP of Clinical and Regulatory Affairs at Neurotech Solutions Ltd. In their earlier career, Joshua worked as a Manager of Regulatory Affairs at Omrix Biopharmaceuticals. Joshua also held various roles at OrNim Medical, Elminda Ltd., and Booz Allen Hamilton.

Joshua Schulman earned their BA in English and Comparative Literature from Columbia University, where they studied from 1992 to 1996. Joshua then pursued their PhD in Physiology and Neuroscience at New York University, where they studied from 1997 to 2004.